Breaking News: Hamilton Thorne’s Going Private Transaction Update Unveiled!
Closing Expected to Occur Effective November 30, 2024
Beverly, Massachusetts and Toronto, Ontario–(Newsfile Corp. – October 17, 2024) – Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology fields, today provided the following update to its going private transaction (the “Transaction”) involving the Company and Cradle Acquisition LLC (the “Purchaser”) pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “Shares” and each, a “Share”).
As previously announced, the Transaction was overwhelmingly approved by its shareholders at a meeting held on September 17, 2024. The Ontario Superior Court of Justice (Commercial List) provided final approval of the Transaction by order dated September 20, 2024. The binding letter of intent that the Purchaser entered into to acquire (the “Acquisition”) the ART product portfolio of Cook Medical (“Cook ART”) with the intention to combine the Cook ART and Hamilton Thorne operations concurrently with the closing of the Transaction has been superseded by definitive agreements. All required regulatory approvals relating to the Transaction and the Acquisition have been obtained by the Company, Cook and the Purchaser, as applicable, or such applicable waiting or review periods have lapsed without objection.
The Company expects the Transaction and the Acquisition will close effective November 30, 2024. In connection with the closing of the Transaction, the Shares will be delisted from the TSX and the Company will apply to cease to be a reporting issuer in each of the applicable jurisdictions in Canada.
How does this affect me?
As an individual investor, if you currently hold shares of Hamilton Thorne, the going private transaction means that your shares will be acquired by the Purchaser, and you will no longer be able to trade them on the TSX. It is important to consider this change in ownership and assess any potential impact on your investment portfolio.
How does this affect the world?
Hamilton Thorne’s going private transaction and acquisition of Cook ART’s product portfolio signify a strategic move in the field of Assisted Reproductive Technologies. The combination of these two entities may lead to new innovations, advancements, and developments in the ART industry, ultimately impacting the world of reproductive health and technology.
Conclusion
In conclusion, Hamilton Thorne’s going private transaction update marks a significant milestone for the company and its shareholders. The anticipated closing of the Transaction on November 30, 2024, will bring about changes in ownership and potential opportunities for growth and collaboration in the ART industry. It will be interesting to see how this development unfolds and its impact on the broader landscape of assisted reproductive technologies.
